The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
951867813 9518678 13 F 201209 20160725 20130912 20160729 EXP PHHY2013BR100414 NOVARTIS 17.31 YR M Y 62.00000 KG 20160729 CN COUNTRY NOT SPECIFIED BR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
951867813 9518678 1 PS EXJADE DEFERASIROX 1 Oral 10 MG/KG, QD (2 DF OF 250 MG) 21882 10 MG/KG DISPERSIBLE TABLET QD
951867813 9518678 2 SS EXJADE DEFERASIROX 1 Oral 15 MG/KG, QD (1000 MG) 21882 15 MG/KG DISPERSIBLE TABLET QD
951867813 9518678 3 SS EXJADE DEFERASIROX 1 Oral 25 MG/KG, QD (3 DF OF 500 MG) 21882 25 MG/KG DISPERSIBLE TABLET QD
951867813 9518678 4 C AAS ASPIRIN 1 Oral 1 DF, QD Y 0 1 DF QD
951867813 9518678 5 C FOLIC ACID. FOLIC ACID 1 Oral 5 MG, QD 0 5 MG QD
951867813 9518678 6 C ZOLOFT SERTRALINE HYDROCHLORIDE 1 Unknown 0
951867813 9518678 7 C DRAMAMINE DIMENHYDRINATE 1 Unknown U 0
951867813 9518678 8 C ALENDRONATE ALENDRONATE SODIUM 1 Unknown 0
951867813 9518678 9 C DESFERAL DEFEROXAMINE MESYLATE 1 Unknown U 0
951867813 9518678 10 C HYDREA HYDROXYUREA 1 Oral 3 DF, QD 0 3 DF TABLET QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
951867813 9518678 1 Sickle cell anaemia
951867813 9518678 4 Product used for unknown indication
951867813 9518678 5 Sickle cell anaemia
951867813 9518678 6 Product used for unknown indication
951867813 9518678 7 Product used for unknown indication
951867813 9518678 8 Product used for unknown indication
951867813 9518678 9 Product used for unknown indication
951867813 9518678 10 Sickle cell anaemia

Outcome of event

Event ID CASEID OUTC COD
951867813 9518678 HO
951867813 9518678 OT
951867813 9518678 LT

Reactions reported

Event ID CASEID DRUG REC ACT PT
951867813 9518678 Abasia
951867813 9518678 Arthralgia
951867813 9518678 Aspergillus infection
951867813 9518678 Back pain
951867813 9518678 Bacterial infection
951867813 9518678 Candida infection
951867813 9518678 Cardiac disorder
951867813 9518678 Contusion
951867813 9518678 Dyspnoea
951867813 9518678 Fall
951867813 9518678 Fatigue
951867813 9518678 Haemoglobin decreased
951867813 9518678 Headache
951867813 9518678 Hypoxia
951867813 9518678 Infarction
951867813 9518678 Ischaemia
951867813 9518678 Lethargy
951867813 9518678 Lung disorder
951867813 9518678 Malaise
951867813 9518678 Mental disorder
951867813 9518678 Pain
951867813 9518678 Pneumonia
951867813 9518678 Pulmonary hypertension
951867813 9518678 Pulmonary thrombosis
951867813 9518678 Pyrexia
951867813 9518678 Respiratory arrest
951867813 9518678 Scratch
951867813 9518678 Serum ferritin increased
951867813 9518678 Sickle cell anaemia with crisis
951867813 9518678 Tachycardia
951867813 9518678 Vasoconstriction
951867813 9518678 Vena cava thrombosis
951867813 9518678 Vomiting

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
951867813 9518678 1 20120413 0
951867813 9518678 4 201209 201309 0